The Negative Pressure Wound Therapy (NPWT) Market is experiencing robust global growth driven by the increasing prevalence of chronic wounds, diabetic foot ulcers, pressure ulcers, and surgical wounds, which are fueling the demand for advanced wound management technologies. Healthcare providers are turning more and more to portable, disposable and digitally connected NPWT systems to speed wound healing, reduce the risk of infection and improve patient outcomes. Innovations such as smart pressure monitoring, IoT-enabled wound management, canister-free technologies, and home-based wound care solutions are revolutionising modern wound treatment by increasing patient comfort and healthcare efficiency.
The global Negative Pressure Wound Therapy Market was valued at USD 2.79 Billion in 2025 and is projected to reach USD 5.35 Billion by 2035, growing at a CAGR of 6.73% during the forecast period 2026-2035. The market growth is attributed to the increasing prevalence of chronic wounds, increasing prevalence of diabetes, increasing adoption of advanced wound care technologies, and increasing adoption of portable NPWT devices in hospitals, ambulatory surgery centres, and home healthcare settings. Increasing technological innovations in digital wound monitoring, smart sensors, and patient-centric therapy systems are expected to further propel the growth of the market across the globe.
Key Players
Some of the major companies operating in the Negative Pressure Wound Therapy (NPWT) Market are 3M Company, Smith & Nephew plc, ConvaTec Group plc, Mölnlycke Health Care AB, Cardinal Health, Inc., Medela AG, Paul Hartmann AG, Talley Group Ltd., Genadyne Biotechnologies, Inc., DeRoyal Industries, Inc., Devon Medical Products, ATMOS MedizinTechnik GmbH & Co. KG, Carilex Medical GmbH, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., BSN Medical GmbH, Equinox Medical, Shandong Weigao Group, Pensar Medical, and Innovative Therapies, Inc.
Strategic Developments & Industry Innovations
-
3M Company expanded its V.A.C. Therapy and Veraflo portfolio in April 2025 by introducing integrated dressing technologies and enhanced wound monitoring capabilities, improving infection control and advanced wound care management workflows.
-
Smith & Nephew plc launched the RENASYS TOUCH NPWT System in May 2025, featuring smart pressure sensors, touchscreen controls, and a lightweight portable design that improves treatment precision and patient mobility.
-
ConvaTec Group plc showcased its advanced wound care innovation pipeline during the European Wound Management Association Conference in March 2025, highlighting next-generation NPWT technologies focused on faster healing, improved usability, and enhanced patient outcomes.
The Following Are the Leading Companies in the Global Negative Pressure Wound Therapy (NPWT) Industry:
1. 3M Company: Leading Innovation in Advanced Negative Pressure Wound Therapy
3M Company is a global leader in advanced wound care, with its V.A.C. Therapy systems being widely used. The company offers a full portfolio of NPWT solutions that are designed to promote wound healing, reduce the risk of infection and improve clinical outcomes in hospitals, surgical centres and home healthcare settings.
3M’s investments in digital wound monitoring, portable therapy systems and advanced dressing technologies continue to expand its leadership in evidence-based wound management and enhanced patient comfort and healthcare efficiencies across the globe.
2. Smith & Nephew plc: Transforming Portable and Single-Use Wound Care Technologies
Smith & Nephew has a strong position in the NPWT market with PICO Single Use NPWT System and RENASYS product portfolio. The company’s solutions are focused on portability, ease of use and improved patient mobility, while ensuring effective wound healing across both acute and chronic wound applications.
Smith & Nephew’s ongoing innovation in light therapy systems, smart pressure management and home-based wound care continues to expand access to advanced wound treatment for healthcare providers and patients.
3. ConvaTec Group plc: Expanding Smart Wound Care Through Patient-Centered Innovation
ConvaTec Group plc is a global leader in advanced wound care, with the Avance Solo NPWT System, and a complete portfolio of wound management. The company's commitment is to infection prevention, effective exudate management and cost effective wound care in the clinical and home care environments.
The company’s ongoing investments in digital wound technologies, sustainable product development and patient-centric innovation are driving better healing outcomes while further cementing its position in this rapidly developing NPWT market.
Future Outlook of the Global Negative Pressure Wound Therapy (NPWT) Market
The Negative Pressure Wound Therapy (NPWT) Market is expected to be on the rise with the ongoing developments in the healthcare sector, the market is likely to be focused on advanced wound care, early intervention and home-based treatment models. Future innovations such as AI-assisted wound assessment, IoT-enabled remote monitoring, smart pressure regulation, connected healthcare platforms and disposable NPWT technologies are expected to improve clinical outcomes while reducing treatment costs and hospital stays.
3M Company, Smith & Nephew plc, ConvaTec Group plc and others are leading the way in innovation in advanced wound care, with the development of portable, smart and patient friendly NPWT solutions. With the prevalence of chronic wounds on the rise worldwide and the trend towards personalised and decentralised care continuing, negative pressure wound therapy will likely play an even larger role in wound care moving forward.
